Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    mo22097
Show Display Options
Rank Status Study
1 Recruiting A Study of Avastin (Bevacizumab) in Combination With Standard of Care Treatment in Patients With Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Standard of care treatment;   Drug: bevacizumab [Avastin]

Indicates status has not been verified in more than two years